Dalpicilib Plus Cetuximab Shows Promise in Resistant Head and Neck Cancer
In a groundbreaking advancement for the treatment of head and neck squamous cell carcinoma (HNSCC), researchers have unveiled the promising ...
Tag: Phase II clinical trial results
IBI318 Plus Lenvatinib Tackles Resistant Lung Cancer
In a groundbreaking development in the realm of cancer immunotherapy, a recent Phase II clinical trial has unveiled promising results ...
New Triple Therapy Shows Promise for Advanced Liver Cancer
A groundbreaking phase II clinical trial has unveiled promising results in the fight against advanced hepatocellular carcinoma (HCC) by combining ...
Phase II Study Finds Iza-Bren Plus Osimertinib Achieves 100% Response Rate in EGFR-Mutated NSCLC
In a groundbreaking advancement for the treatment of non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations, ...
Innovative Strategy Could Prevent Breast Cancer Recurrence
In a groundbreaking advancement in oncology, researchers at the Abramson Cancer Center of the University of Pennsylvania have unveiled results ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!